» Authors » Laura M Sawyer

Laura M Sawyer

Explore the profile of Laura M Sawyer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 164
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Elkind M, Witte K, Kasner S, Sawyer L, Grimsey Jones F, Rinciog C, et al.
BMC Cardiovasc Disord . 2023 Jan; 23(1):45. PMID: 36698055
Background: Insertable cardiac monitors (ICMs) are a clinically effective means of detecting atrial fibrillation (AF) in high-risk patients, and guiding the initiation of non-vitamin K oral anticoagulants (NOACs). Their cost-effectiveness...
2.
McInnes I, Sawyer L, Markus K, LeReun C, Sabry-Grant C, Helliwell P
RMD Open . 2022 Mar; 8(1). PMID: 35321874
Introduction: Randomised controlled trials (RCTs) have compared biological and targeted systemic disease-modifying antirheumatic drugs (DMARDS) against placebo in psoriatic arthritis (PsA); few have compared them head to head. Objectives: To...
3.
Wright E, Yasmeen N, Malottki K, Sawyer L, Borg E, Schwenke C, et al.
Dermatol Ther (Heidelb) . 2020 Dec; 11(1):181-220. PMID: 33351178
Introduction: A range of treatments are available for moderate-to-severe psoriasis; however, there remains a paucity of direct comparisons of these in head-to-head trials. Network meta-analyses (NMA) allow comparisons of these...
4.
Sawyer L, Witte K, Reynolds M, Mittal S, Grimsey Jones F, Rosemas S, et al.
J Comp Eff Res . 2020 Dec; 10(2):127-141. PMID: 33300381
We assessed cost-effectiveness of insertable cardiac monitors (ICMs) in a US cryptogenic stroke population. We modelled lifetime costs and quality-adjusted life years for three monitoring strategies post cryptogenic stroke: ICM...
5.
Yasmeen N, Sawyer L, Malottki K, Levin L, Apol E, Jemec G
J Dermatolog Treat . 2020 Mar; 33(1):204-218. PMID: 32202445
Purpose: To compare PASI outcomes of approved biologics and apremilast after 1 year of treatment. Methods: A systematic review identified RCTs and long-term extensions reporting PASI 75, 90, and 100...
6.
Balak D, Carrascosa J, Gregoriou S, Calzavara-Pinton P, Bewley A, Antunes J, et al.
J Dermatolog Treat . 2020 Jan; 32(7):701-708. PMID: 31940225
Purpose: To compare the short-term cost and effectiveness of calcipotriol/betamethasone dipropionate (Cal/BD) cutaneous foam against nonbiologic systemics in psoriasis patients for whom oral systemic or topical therapy is considered appropriate...
7.
Sawyer L, Malottki K, Sabry-Grant C, Yasmeen N, Wright E, Sohrt A, et al.
PLoS One . 2019 Aug; 14(8):e0220868. PMID: 31412060
Introduction: New generation biologics, including interleukin (IL)-17 and IL-23 inhibitors, have delivered higher rates of skin clearance than older treatments in head-to-head studies. However, studies comparing these new biologics directly...
8.
Rinciog C, Sawyer L, Diamantopoulos A, Elkind M, Reynolds M, Tsintzos S, et al.
Open Heart . 2019 Jul; 6(1):e001037. PMID: 31297227
Objective: To evaluate the cost-effectiveness of insertable cardiac monitors (ICMs) compared with standard of care (SoC) for detecting atrial fibrillation (AF) in patients at high risk of stroke (CHADS >2),...
9.
Diamantopoulos A, Sawyer L, Lip G, Witte K, Reynolds M, Fauchier L, et al.
Int J Stroke . 2016 Jan; 11(3):302-12. PMID: 26763916
Background And Aims: Documentation of atrial fibrillation is required to initiate oral anticoagulation therapy for recurrent stroke prevention. Atrial fibrillation often goes undetected with traditional electrocardiogram monitoring techniques. We evaluated...
10.
Bermingham S, Hughes R, Fenu E, Sawyer L, Boxall E, Kennedy P, et al.
Value Health . 2015 Sep; 18(6):800-9. PMID: 26409607
Background: Seven drugs are licensed for the treatment of chronic hepatitis B (CHB) in the United Kingdom. Which initial treatment, secondary therapy, and whether antivirals should be given alone or...